EP0877623A4 - - Google Patents

Info

Publication number
EP0877623A4
EP0877623A4 EP96924312A EP96924312A EP0877623A4 EP 0877623 A4 EP0877623 A4 EP 0877623A4 EP 96924312 A EP96924312 A EP 96924312A EP 96924312 A EP96924312 A EP 96924312A EP 0877623 A4 EP0877623 A4 EP 0877623A4
Authority
EP
European Patent Office
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP96924312A
Other versions
EP0877623A1 (en
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of EP0877623A4 publication Critical patent/EP0877623A4/xx
Publication of EP0877623A1 publication Critical patent/EP0877623A1/en
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/08—Clostridium, e.g. Clostridium tetani
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A61K2039/541—Mucosal route
    • A61K2039/543—Mucosal route intranasal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55544—Bacterial toxins
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Urology & Nephrology (AREA)
  • Reproductive Health (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Endocrinology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
EP96924312A 1995-07-07 1996-06-26 Intranasal vaccination against gastrointestinal disease Withdrawn EP0877623A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US49922995A 1995-07-07 1995-07-07
US499229 1995-07-07
PCT/US1996/010987 WO1997002835A1 (en) 1995-07-07 1996-06-26 Intranasal vaccination against gastrointestinal disease

Publications (2)

Publication Number Publication Date
EP0877623A4 true EP0877623A4 (enrdf_load_html_response) 1998-11-18
EP0877623A1 EP0877623A1 (en) 1998-11-18

Family

ID=23984386

Family Applications (1)

Application Number Title Priority Date Filing Date
EP96924312A Withdrawn EP0877623A1 (en) 1995-07-07 1996-06-26 Intranasal vaccination against gastrointestinal disease

Country Status (8)

Country Link
EP (1) EP0877623A1 (enrdf_load_html_response)
JP (1) JPH11510793A (enrdf_load_html_response)
CN (1) CN1195993A (enrdf_load_html_response)
AU (1) AU722653B2 (enrdf_load_html_response)
CA (1) CA2226392A1 (enrdf_load_html_response)
NZ (1) NZ312876A (enrdf_load_html_response)
WO (1) WO1997002835A1 (enrdf_load_html_response)
ZA (1) ZA965737B (enrdf_load_html_response)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6153201A (en) * 1993-03-09 2000-11-28 University Of Rochester Oral immunization with papillomavirus virus-like particles
US6969520B2 (en) 1997-10-20 2005-11-29 Acambis Inc. Active immunization against clostridium difficile disease
US6585975B1 (en) * 1998-04-30 2003-07-01 Acambis, Inc. Use of Salmonella vectors for vaccination against helicobacter infection
US6974573B2 (en) 1999-11-01 2005-12-13 Mucovax Holdings, B.V. Antibody production in farm animals
US7074454B1 (en) 1999-11-01 2006-07-11 Mucovax Holding B.V. Production of mammary secretion antibodies in farm animals
EP1226176B1 (en) * 1999-11-01 2006-02-08 MucoVax Holding B.V Production of mammary secretion antibodies in farm animals
GB0029919D0 (en) * 2000-12-07 2001-01-24 Chiron Spa Helicobacter pylori prime & boost vaccination
US8465754B2 (en) 2007-05-28 2013-06-18 Kitasato Daiichi Sankyo Vaccine Co., Ltd. Bordetella parapertussis whole-cell vaccine composition
EP2198007B1 (en) 2007-09-14 2017-10-25 Sanofi Pasteur Biologics, LLC Pharmaceutical compositions containing clostridium difficile toxoids a and b
WO2010063693A1 (en) * 2008-12-03 2010-06-10 Boehringer Ingelheim Vetmedica Gmbh Process for production of vaccines
AU2010325992A1 (en) * 2009-12-02 2012-05-31 Tufts University Atoxic recombinant holotoxins of Clostridium difficile as immunogens
PT2699587T (pt) 2011-04-22 2019-09-05 Wyeth Llc Composições relacionadas com uma toxina de clostridium difficile mutante e métodos da mesma
WO2013071409A1 (en) 2011-11-18 2013-05-23 National Research Council Of Canada (Nrc) Clostridium difficile lipoteichoic acid and uses thereof
BR122016023101B1 (pt) 2012-10-21 2022-03-22 Pfizer Inc Polipeptídeo, composição imunogênica que o compreende, bem como célula recombinante derivada de clostridium difficile

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4141970A (en) * 1975-05-07 1979-02-27 Internationale Octrooimaatschappij "Octropa" B.V. Method for enhancing the resistance of new born mammalian young to gastro-intestinal infections
US4713240A (en) * 1985-04-04 1987-12-15 Research Corporation Vaccines based on insoluble supports
WO1993021950A1 (en) * 1992-04-28 1993-11-11 Medeva Holdings Bv Vaccine compositions for mucosal delivery
WO1994002173A1 (en) * 1992-07-16 1994-02-03 Oxford University Multiple particulate antigen delivery system

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4944942A (en) * 1987-08-27 1990-07-31 Mobay Corporation Intranasal vaccination of horses with inactivated microorganisms or antigenic material
JP2849632B2 (ja) * 1988-04-08 1999-01-20 社団法人北里研究所 ワクチン製剤
US5601823A (en) * 1989-10-31 1997-02-11 Ophidian Pharmaceuticals, Inc. Avian antitoxins to clostridium difficle toxin A

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4141970A (en) * 1975-05-07 1979-02-27 Internationale Octrooimaatschappij "Octropa" B.V. Method for enhancing the resistance of new born mammalian young to gastro-intestinal infections
US4713240A (en) * 1985-04-04 1987-12-15 Research Corporation Vaccines based on insoluble supports
WO1993021950A1 (en) * 1992-04-28 1993-11-11 Medeva Holdings Bv Vaccine compositions for mucosal delivery
WO1994002173A1 (en) * 1992-07-16 1994-02-03 Oxford University Multiple particulate antigen delivery system

Non-Patent Citations (6)

* Cited by examiner, † Cited by third party
Title
DATABASE BIOSIS, PREV199395016770, & RESEARCH IN VIROLOGY, 1992, VOL 143, 269-278 *
DATABASE MEDLINE WALDO FB: "Nasal immunization with tetanus toxoid increases the subsequent systemic dimeric IgA1 antibody response to intramuscular immunization", XP002063192 *
INFECTION AN IMMUNITY, VOL 62(1), 1994, 15-23 *
JOURNAL OF CLINICAL AND LABORATORY IMMUNOLOGY, 1991, 34(3) 125-129 *
LIBBY J.M. ET AL: "Effects of the two toxins of Clostridium difficile in antibiotic associated cecitis in hamsters", INFECTION AND IMMUNITY, vol. 36, no. 2, 1982, WASHINGTON US, pages 822 - 829, XP002063191 *
See also references of WO9702835A1 *

Also Published As

Publication number Publication date
CN1195993A (zh) 1998-10-14
AU722653B2 (en) 2000-08-10
NZ312876A (en) 2000-06-23
ZA965737B (en) 1997-05-13
AU6479996A (en) 1997-02-10
WO1997002835A1 (en) 1997-01-30
CA2226392A1 (en) 1997-01-30
JPH11510793A (ja) 1999-09-21
EP0877623A1 (en) 1998-11-18

Similar Documents

Publication Publication Date Title
BR122012014331A2 (enrdf_load_html_response)
BRPI9612258B1 (enrdf_load_html_response)
BRPI9612138B1 (enrdf_load_html_response)
CH0741373H1 (enrdf_load_html_response)
BR7501503U (enrdf_load_html_response)
BR7502120U (enrdf_load_html_response)
ECSDI950264S (enrdf_load_html_response)
CN3032332S (enrdf_load_html_response)
CN3032692S (enrdf_load_html_response)
CN3029928S (enrdf_load_html_response)
CN3030154S (enrdf_load_html_response)
CN3030197S (enrdf_load_html_response)
CN3030225S (enrdf_load_html_response)
CN3030296S (enrdf_load_html_response)
CN3030415S (enrdf_load_html_response)
CN3030489S (enrdf_load_html_response)
CN3030542S (enrdf_load_html_response)
CN3030543S (enrdf_load_html_response)
CN3037560S (enrdf_load_html_response)
CN3031001S (enrdf_load_html_response)
CN3031350S (enrdf_load_html_response)
CN3031655S (enrdf_load_html_response)
CN3031742S (enrdf_load_html_response)
CN3031926S (enrdf_load_html_response)
BY5258C1 (enrdf_load_html_response)

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 19980115

A4 Supplementary search report drawn up and despatched

Effective date: 19980522

AK Designated contracting states

Kind code of ref document: A4

Designated state(s): AT BE CH DE DK ES FR GB IE IT LI NL SE

Kind code of ref document: A1

Designated state(s): AT BE CH DE DK ES FR GB IE IT LI NL SE

17Q First examination report despatched

Effective date: 19981223

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20010921